Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder

被引:0
|
作者
De Braud, Filippo
Danesi, Romano
Curigliano, Giuseppe
Giovanetti, Elisa
De Cobelli, Ottavio
De Pas, Tommaso
Mey, Valentina
Spitaleri, Gianluca
Pece, Salvatore
Noberasco, Cristina
Nannizzi, Sara
Verweij, Fabrizio
Renne, Giuseppe
McVie, Gordon
Del Tacca, Mario
机构
[1] European Inst Oncol, Clin Pharmacol & New Drugs Unit, Milan, Italy
[2] Univ Pisa, Sch Med, Div Pharmacol & Chemotherapy, Pisa, Italy
[3] European Inst Oncol, Div Urol, Milan, Italy
[4] European Inst Oncol, Dept Expt Oncol, Milan, Italy
[5] European Inst Oncol, Dept Pathol, Milan, Italy
[6] European Inst Oncol, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3116
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder
    Verweij, Fabrizio
    Matel, Victor D.
    Scardino, Epifanio
    Rocco, Bernardo
    Musi, Gennaro
    Besana, Umberto
    Zambito, Stefano
    Pimentel, Marcelo
    Pedroso, Eduardo
    de Cobelli, Ottavio
    de Braud, Filippo
    Curigliano, Giuseppe
    Spitaleri, Gianluca
    Pece, Salvatore
    Danesi, Romano
    Mey, Valentina
    Giovanetti, Elisa
    Nanizzi, Sara
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 81 - 81
  • [2] Evaluation of superficial bladder transitional cell carcinoma (TCC)
    不详
    [J]. JOURNAL OF ENDOUROLOGY, 2004, 18 : A38 - A38
  • [3] Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder
    Mohanty, N. K.
    Nayak, R. L.
    Arora, R. P.
    Saxena, S.
    [J]. BJU INTERNATIONAL, 2007, 99 : 14 - 14
  • [4] Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder.
    Bouzid, K
    Ferhat, R
    Bounedjar, A
    Mahfouf, H
    Smaili, F
    Adjali, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 407S - 407S
  • [5] Intra vesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of the bladder: Final results
    Bounedjar, A.
    Ferhat, R.
    Smaili, F.
    Bouzid, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Evaluation of superficial bladder transitional cell carcinoma (TCC) by optical coherence tomography (OCT)
    Manyak, MJ
    Gladkova, ND
    Schwartz, A
    Zolfaghari, L
    Zara, J
    Iksanov, R
    Feldchtein, FI
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 87 - 87
  • [7] BACILLUS CALMETTE-GUERIN: TREATMENT FOR SUPERFICIAL TRANSITIONAL CELL CARCINOMA (TCC) OF THE BLADDER
    Fornia, Samanta
    Ferretti, Stefania
    Campobasso, Davide
    Barbieri, Antonio
    Maestroni, Umberto
    Ziglioli, Francesco
    Cortellini, Pietro
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1523 - 1523
  • [8] Results at 5 years of intra vesical gemcitabine (G) single agent as adjuvant chemotheray in superficial transitional cell carcinoma (TCC) of the bladder
    Smaili, F.
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] UROTHELIAL RELAPSE OF THE URETHRA DURING FOLLOW UP OF THE SUPERFICIAL TRANSITIONAL CELL CARCINOMA (TCC) OF THE BLADDER
    Pizzirusso, Gerardo
    Boschi, Gian Luigi
    Calcopietro, Carlo
    Dal Pozzo, Claudio
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1507 - 1508
  • [10] Paclitaxel, carboplatin and gemcitabine (PCG) as neoadjuvant therapy in patients with locally advanced transitional cell carcinoma (TCC) of the bladder.
    Smith, DC
    Bhandari, M
    Hussain, M
    Montie, JE
    Wood, DP
    Lee, CT
    Petrylak, DP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 392S - 392S